Adzenys ER (Neos Therapeutics, LP)
Welcome to the PulseAid listing for the Adzenys ER drug offered from Neos Therapeutics, LP. This Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Neos Therapeutics, LP |
NON-PROPRIETARY NAME: | Amphetamine |
SUBSTANCE NAME: | AMPHETAMINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | SUSPENSION, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-09-16 |
END MARKETING DATE: | 0000-00-00 |
Adzenys ER HUMAN PRESCRIPTION DRUG Details:
Item Description | Adzenys ER from Neos Therapeutics, LP |
LABELER NAME: | Neos Therapeutics, LP |
DEA SCHEDULE: | CII
|
ACTIVE STRENGTH: | 1.25(mg/mL) |
START MARKETING DATE: | 2017-09-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 70165-003_8e3677f7-b759-4a96-b064-2382a74c4af1 |
PRODUCT NDC: | 70165-003 |
APPLICATION NUMBER: | NDA204325 |
Other AMPHETAMINE Pharmaceutical Manufacturers / Labelers: